Salt Lake City, UT, United States of America

Reshma Shetty


Average Co-Inventor Count = 7.8

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2003-2008

Loading Chart...
4 patents (USPTO):

Title: Reshma Shetty: Pioneering Innovation in Peptide Research

Introduction

Reshma Shetty, an accomplished inventor based in Salt Lake City, Utah, has made significant contributions to the field of peptide research. With a total of four patents attributed to her name, Shetty specializes in the innovative study of conotoxin peptides derived from the venom of cone snails.

Latest Patents

Among her latest inventions are two groundbreaking patents focusing on conotoxin peptides. The first patent revolves around the development of relatively short peptides, termed α-conotoxins, which consist of approximately 10-25 residues in length. These peptides are found in minute amounts in the venom of cone snails and are characterized by the presence of two disulfide bonds. The second patent involves I-superfamily conotoxins, which encompass short peptides of about 30-50 residues, also extracted from cone snail venom. These I-conotoxins ideally include four disulfide bonds, underscoring their complex structure and potential therapeutic applications.

Career Highlights

Throughout her career, Shetty has been associated with the University of Utah Research Foundation, where she has played a crucial role in advancing research in peptide-based innovations. Her work not only exemplifies her expertise but also contributes significantly to the broader scientific community's understanding of these complex compounds.

Collaborations

Reshma Shetty has collaborated with notable figures in her field, including Craig S. Walker and Baldomero M. Olivera. These collaborations highlight the importance of teamwork in scientific research and innovation, fostering an environment where groundbreaking ideas can thrive.

Conclusion

Reshma Shetty's inventive spirit and dedication to peptide research continue to inspire and drive innovation within the scientific community. Her patents on α-conotoxin and I-superfamily conotoxins represent significant milestones, paving the way for future advancements in the application of peptides in various therapeutic contexts.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…